Trial NCT02748564

View at ClinicalTrials.gov 
Org. Study IDs: 091602
Secondary IDs: NCI-2016-00466 P30CA072720 Pro20160000394

Last trial update was posted on 2023-08-03

MeSH Interventions

Aldesleukin Interleukin-2 Pembrolizumab

MeSH Conditions

Melanoma Melanoma, Cutaneous Malignant Skin Neoplasms

Other Conditions

Metastatic Melanoma Stage III Mucosal Melanoma of the Head and Neck Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Stage IVA Mucosal Melanoma of the Head and Neck Stage IVB Mucosal Melanoma of the Head and Neck Stage IVC Mucosal Melanoma of the Head and Neck

Stopping Reasons

Study Complete

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID